Papillary serous cystadenocarcinoma explained

Papillary serous cystadenocarcinomas are the most common form of malignant ovarian cancer making up 26 percent of ovarian tumours in women aged over 20 in the United States.^[1]

As with most ovarian tumours, due to the lack of early signs of disease these tumours can be large when discovered and have often metastasized, often by spreading along the peritoneum.^[2]

Histopathology

Papillary serous cystadenocarcinomas may exhibit psammoma bodies upon histopathology.^[3]

Epidemiology

Notes and References

1. Book: Chapter 16: Cancers of the Ovary . Kosary CL . 133–144 . National Cancer Institute . SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics . Ries LA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ . SEER Program . NIH Pub. No. 07-6215 . Bethesda, MD . 2007 . dead . https://web.archive.org/web/20131010123756/http://seer.cancer.gov/publications/survival/ . 2013-10-10 .
2. Web site: The Internet Pathology Laboratory for Medical Education. The University of Utah Eccles Health Sciences Library. 2009-06-27.
3. http://library.med.utah.edu/WebPath/FEMHTML/FEM072.html Ovarian papillary serous cystadenocarcinoma